Franz B. Humer, Director at Allogene Therapeutics, Inc. (ALLO), sold 9,221 shares at $2.16 ($20K) on 2024-12-05, disclosed to the SEC on 2024-12-09.
Open-market sale of $20k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |